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Introduction
Many terminologies have been used to define babies who are small for gestational age. These include small for gestational age (SGA), intrauterine growth retardation IUGR) and fetal growth restriction. Most of the time, SGA is used for newborn, and IUGR for fetus. Babies weighing less than 10 th percentile of their ageadjusted birth weight are considered SGA. [1] Early detection of SGA risk in fetus will help investigators evaluate healthcare expenditures of pregnancy and decide on most suitable time for delivery. In addition, early diagnosis of IUGR can provide up to four times better prognosis for SGA babies. [2] Unfortunately, despite modern obstetric methods, IUGR is still a determinative factor in perinatal mortality and morbidity. [3] Fetuses with extreme preterm IUGR represent the high risk group for neonatal mortality and morbidity. [4, 5] When long-term outcomes are taken into consideration, researchers have reported a wide spectrum of outcomes, ranging from minor decrease in IQ to serious increase in risk for cerebral palsy. [6, 7] Careful monitoring of fetal growth and optimal determination of type and timing of delivery provide the best possible result. Lubchenco et al. detected a dramatic increase in mortality and morbidity if birth weight of newborn delivered at any gestational age is lower than the 10 th percentile of gestational age-adjusted normal birth weight.
[8] Perinatal mortality and morbidity increase significantly when birth weight decreases from the 10 th percentile. [9] Generally, infants born with body weight varying from 1500 to 2500 grams between 38 th and 42 nd gestational weeks have 5 to 30 times higher perinatal morbidity and mortality rates than those with body weight between 10 th and 90 th percentiles. Incidence of perinatal morbidity and mortality increases multifold in newborns weighing less than 1500 grams. [10] In the normal population, median value of pregnancy-associated plasma protein-A (PAPP-A) is 1.0 multiples of median (MoM). [11, 12] There is a direct proportion between serum PAPP-A level, weight of placenta, and birth weight, while an inverse proportion exists between serum PAPP-A level and body weight of the pregnant woman. [13, 14] When fetuses with chromosomal abnormalities were excluded from the study, PAPP-A levels in the first trimester were found to be correlated with pregnancy complications. In some studies, higher levels of PAPP-A in first trimester correlated with preeclampsia; however, in many other studies, authors reported lack of any correlation between PAPP-A levels and preeclampsia. [15, 16] In other words, this issue has not been determined conclusively.
Another hormone, beta subunit of human chorionic gonadotropin (βhCG) has also been routinely used as a component of double test for monitoring pregnant women. Decreased level of βhCG in the first trimester has been found to be correlated with low birth weight and spontaneous abortus. In recurrent miscarriages and unexplained cases of infertility, mutations in βhCG gene transcription have been detected. [15, 17, 18] Weakened placentation and smaller placenta have been associated with lower βhCG levels in first and second trimesters of complicated pregnancies. [19] Between 11 and 14 gestational weeks, 5% of fetuses had nuchal translucency (NT) above 95 th percentile. Many of these fetuses have normal chromosomal and anatomic structure during antenatal period and at birth; however, they have higher risk of developing major cardiac anomalies, other structural abnormalities, rarely seen genetic syndromes, and other adverse pregnancy outcomes. [20] [21] [22] Maternal serum alfa fetoprotein (msAFP) is another hormone, evaluated between 16 and 18 gestational weeks for Down syndrome and neural tube defects. In the detection of IUGR, some studies have emphasized importance of higher msAFP values. In 2008, Gagnon et al. indicated presence of an association between msAFP value and IUGR. [23] In recent years, the attention of researchers has been concentrated on determination of fetal condition and measurement of flow patterns in fetal vessels. Currently, many randomized controlled studies have demonstrated that using these modalities might decrease fetal mortality rates and delivery of preterm IUGR fetuses caused by unnecessary induction of labor. [24] However, loss of end-diastolic blood flow or presence of retrograde blood flow in umbilical artery heralds adverse fetal outcomes. In cases with normal umbilical artery blood flow, very rarely are significant fetal morbidities detected, and most of the time, constitu-tional growth retardation is reported. [25] More importantly, in fetuses where abnormal Doppler US findings are detected in venous circulation (ductus venosus and umbilical vein), an imminent life-threatening event can occur. [26] Although fetal growth is thought to be very closely related to events occurring during second trimester, recent studies have demonstrated that placental development in first trimester determines the developmental and growth pattern of the fetus. [27, 28] Naturally, potential use of double test (PAPP-A, and βhCG) for early detection of IUGR, which effects fetal prognosis, would be an effective diagnostic modality without incurring additional financial burden.
In 2 large-scale studies performed recently, lower PAPP-A levels were associated with increased risk of being an infant with SGA. [29, 30] Despite detection of closer association between maternal PAPP-A level and birth weight within first trimester in these studies, measurements of crown-rump length (CRL) in first trimester was not investigated.
Furthermore, the authors of these studies did not discuss whether birth weight is correlated with measurements of PAPP-A and CRL, independently or in combination.
The purpose of the present study was both to investigate correlation between infant birth weight and measurement of crown-rump length (CRL), neck translucency (NT), PAPP-A, βHCG, msAFP, and uterine artery notch as detected on Doppler US, and to evaluate their predictive value in the detection of SGA.
Patients and Methods
This investigation was designed as a prospective observational study. Pregnant women in their first trimester who came to the obstetric polyclinic of the hospital between June 2010 and June 2011 for routine visits were included in the study. Patients with multiple pregnancies, systemic disease, or anomalous fetus detected during follow-up were excluded. Approval of the Kartal Dr. Lütfi Kırdar Training and Research Hospital ethics committee was obtained. All patients were informed about the study and provided signed consent forms indicating that they had been given information concerning the study.
A total of 103 patients completed the study. At first admission, height and body weight of all patients were measured, and body mass index (BMI) was calculated. Their obstetric and medical anamneses were recorded. They were asked about smoking status. Their gestational age was confirmed with US examination. Necessary biochemical examinations were requested, and those with abnormal test results were excluded from the study. For first trimester screening tests, follow-up visits were optimally arranged for 11-13+6 weeks. Measurements of CRL and NT were performed. Blood samples were collected for measurement of maternal serum free βHCG and PAPP-A values. Their results were recorded in MoM values appropriate for number of gestational weeks. Between 16th and 18th week, blood samples were drawn to measure maternal serum AFP level and MoM values were recorded. Biochemical markers were measured immediately after blood samples were obtained using Kryptor analyzer (Brahms Diagnostica GmbH, Berlin, Germany). Apart from routine follow-up process, biometric measurements and screening tests for anomalies (if any) were performed. Umbilical artery pulsatility index (PI), resistance index (RI), and systolic/diastolic (S/D) parameters, as well as presence of uterine artery notch on Doppler US were analyzed. Hemoglobin values were determined. Birth weight, gestational weeks, presence of gestational diabetes, preeclamptic, and premature deliveries were recorded. Newborns with birth weight below 10 th percentile constituted the SGA group, and remainder were designated the control group. Based on these criteria, 83 women delivered infants with normal birth weight. Patient data of both groups were compared. For statistical analysis, SPSS software (Statistical Package for Social Sciences version 16.0; SPSS Inc., Chicago, IL, USA) was used. Mean values were compared using independent-t test, and rates were compared using chi-square test. Pearson correlation test was used for the correlation of data with SGA, and p<0.05 was evaluated as the level of statistical significance.
Results
Twenty patients with SGA and 83 with appropriate gestational age (AGA) or normal birth weight babies completed the study. Patient characteristics are shown in Table 1 . Average body weight of mothers with SGA babies was statistically significantly different from mothers who delivered babies with gestational age-adjusted normal body weight (p=0.03). The same result was also demonstrated with Pearson correlation test (p=0.03; r=0.283). Other patient characteristics were the same in both groups.
Mean values for screening biomarkers, CRL, NT measurements, and hemoglobin values in the first trimester are shown in Table 2 . Mean CRL measurements in first trimester did not differ significantly between infants with SGA and age-adjusted normal birth weight babies. Mean PAPP-A, βhCG, and hemoglobin values were comparable between both groups. No difference was observed between mean NT measurements. Table 3 .
Second trimester screening tests were performed on participants within approximately the same gestational week. Biophysical measurements of the fetuses did not differ. Uterine artery notch was more frequently detected in pregnant women who delivered SGA infants, though a statistically significant difference was not observed between groups. Mean AFM MoM measured during second trimester was significantly higher in pregnancies with SGA fetuses (p=0.009). The same findings were also revealed in Pearson correlation test (p=0.028; r=-0.327).
As seen in Table 4 , mean gestational week at birth in each SGA group was significantly less than that of the control group (p=0.018). Prematurity was significantly more frequent in the SGA group relative to the control group (p<0.01). Mean birth weights of the SGA and AGA infants were 2216±581 gr and 3391±386 gr, respectively; however, no intergroup difference was found in hemoglobin values or frequency of gestational diabetes. On the other hand, preeclampsia was more frequently detected in the SGA group (p=0.027).
Male to female ratio of both groups was nearly equivalent. Mean birth weight, CRL, and mean values of serum markers did not differ between male and female infants. Only mean NT value of male fetuses (0.96±0.23) was significantly higher than that of the female fetuses (p=0.005). Biophysical measurements of the fetuses during second trimester were comparable between genders.
Discussion
In 1998, Smith et al. investigated factors affecting low birth weight, comparing smokers and nonsmokers during the first trimester, and observed lower PAPP-A values in smokers. [31] This outcome suggested that PAPP-A secreted from trophoblasts might be related to premature development of fetus and placentation. However, in studies performed separately by Dugoff et al. and Krantz et al., a relatively prominent correlation between low birth weight and PAPP-A levels was not seen. The same results were observed by Spencer et al. in 2008 . [30, 32, 33] Next, they tried to increase predictive impact for early detection of IUGR and added first trimester CRL to PAPP-A. In the study by Leung et al. realized in 2008, the authors revealed that decreases in both first trimester CRL and PAPP-A were independent risk factors for lower birth weight. [34] In the present study, mean PAPP-A values for SGA babies and AGA babies were 1.42±1.077 and 1.35±1.59, respectively, without a significant difference between them.
Like PAPP-A, the biomarker βhCG has been also investigated for the prediction of IUGR. Contrary to PAPP-A, βhCG does not directly affect fetal development. However, its levels may drop related to placental insufficiency. In many studies, the correlation between lower βhCG values and its predictive value for SGA has been considered a debatable issue. [29] Variations in the etiology of SGA may account for differences among study outcomes. In the present study, a statistically significant difference as far as PAPP-A and βhCG values was not detected in the SGA group when com- [30, 32, 36] In the current study, NT values were within normal limits in both groups without any statistically significant difference between groups ( Table 2 ).
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The importance of higher AFP in the prediction of IUGR has been stressed in many studies. In 2008, Gagnon et al. demonstrated a correlation between AFP value and IUGR. [23] Many other studies cited in the literature have supported the results of this study. Morris et al. revealed that AFP levels above 2 MoM, apart from anomalies, could detect low birth weight in 27% of cases. [37] Also in the present study, a significantly higher mean AFP level was detected in the group with SGA babies.
In the present study, first trimester 11-13+6 week CRL and fetal biophysical measurements at gestational 20 to 24 weeks for SGA were not different when compared with estimates for normal term pregnant women. However, in a study performed by Law et al., the authors detected significant correlations between birth weight of fetuses at 18 th to 22 nd week gestational age and biophysical profiles such as BPD, HC, AC, and placenta volume. In the same study, uterine artery PI in first and second trimesters was found to be correlated with IUGR. According to their outcomes, uterine artery PI is an independent indicator for IUGR. [38] The present study results are in accordance with other studies that demonstrated correlations between uterine artery blood flow and IUGR. [39] [40] [41] Uterine artery PI reflects placental resistance against uterine blood flow, and thus perfectly evaluates placental function. In the current study also, when presence of uterine artery notch, which is an indicator of this resistance, was examined, a significantly greater number of uterine notches were seen in IUGR babies born between 20 th and 24 th gestational week. This result confirms the outcomes of other studies.
Rates of gestational diabetes were similar in both groups, while frequency of preeclampsia was expectedly, and significantly, higher among SGA babies. In the present study, IUGR was detected in 20% of fetuses. This condition can be explained by the fact that our hospital is a reference hospital with high-risk patients at our clinics.
When premature birth rates are reviewed, it can be seen that 30% of the SGA babies and only 6.7% of the control group were premature. These outcomes complied with etiology and treatment of IUGR.
In conclusion, in this study it has been demonstrated that first trimester serum markers in the group with SGA do not differ significantly from those of the normal group. On the other hand, we have shown that AFP value measured between 16 and 18 gestational weeks, and uterine artery Doppler values detected between 20 and 24 gestational weeks can be effective in predicting IUGR. Although studies cited in the literature have considered varying serum markers, they haven't demonstrated a significant and effective first trimester US or serum marker that will detect IUGR at an early stage. The present study supports these findings.
